ConductScience.org, home

Paper573129

Treatment of hypertrophic obstructive cardiomyopathy with verapamil.

Kaltenbach M and 5 others. Br Heart J, 1979. Cited by 205 papers, by iCite.

Cite this record

ConductScience Library. Treatment of hypertrophic obstructive cardiomyopathy with verapamil. Papers, record 573129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/573129

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of hypertrophic obstructive cardiomyopathy with verapamil.
PubMed
Journal
Br Heart J
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
205
iCite
Relative citation ratio, by iCite
7.18
iCite
Revised in PubMed
2019-05-03
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kaltenbach MM
2Hopf RR
3Kober GG
4Bussmann WDW D
5Keller MM
6Petersen YY

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cardiomyopathy, HypertrophicMajor topic
VerapamilMajor topic
Adult
Cardiac Catheterization
Coronary Angiography
Coronary Vessels
Electrocardiography
Female
Heart
Hemodynamics
Humans
Male
Myocardial Contraction

Source PubMed

Download CSV of topics

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
173643Mitochondrial calcium overload: A general mechanism for cell-necrosis in muscle diseases.Lancet1976https://conductscience.org/library/papers/73643PubMed
217415[Drug therapy of coronary heart disease (author's transl)].Arzneimittelforschung1977https://conductscience.org/library/papers/17415PubMed
34277967[Width and cross section of epicardial coronary arteries in relation to myocardial hypertrophy].Z Kardiol1974https://conductscience.org/library/papers/4277967PubMed
44191245Congestive and hypertrophic cardiomyopathies. A decade of study.Lancet1970https://conductscience.org/library/papers/4191245PubMed
51169134Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients.Circulation1975https://conductscience.org/library/papers/1169134PubMed
6945645[Late results of surgery in muscular subvalvular aortic stenosis].Z Kardiol1976https://conductscience.org/library/papers/945645PubMed
74586631Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy.Br Heart J1973https://conductscience.org/library/papers/4586631PubMed
88298[Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl)].Dtsch Med Wochenschr1976https://conductscience.org/library/papers/8298PubMed
94735938Hypertrophic subaortic stenosis. Clinical and hemodynamic effects of long-term propranolol therapy.Am J Cardiol1973https://conductscience.org/library/papers/4735938PubMed
10936724[Course observations of hypertrophic obstructive myocardiopathy].Z Kardiol1976https://conductscience.org/library/papers/936724PubMed
111122800[Cine-angiographic determination of ventricular volumes with the help of a computer (author's transl)].Dtsch Med Wochenschr1975https://conductscience.org/library/papers/1122800PubMed
125462284Effects of propranolol on response to exercise in hypertrophic obstructive cardiomyopathy.Br Heart J1970https://conductscience.org/library/papers/5462284PubMed

Download CSV of references

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 205 citations.

PMIDTitleJournalYearIn PapersSource
41649583CYP2C19 genotyping and mavacamten: predicting outcomes in normal, intermediate and rapid metabolisers in obstructive hypertrophic cardiomyopathy.Eur J Clin Pharmacol2026https://conductscience.org/library/papers/41649583PubMed
40993768Current and emerging medical and surgical therapy in hypertrophic cardiomyopathy.J Cardiovasc Imaging2025https://conductscience.org/library/papers/40993768PubMed
40377024Efficacy of pharmacological therapies in reducing outflow tract obstruction in patients with obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis.Eur Heart J Cardiovasc Pharmacother2025https://conductscience.org/library/papers/40377024PubMed
39943699Treatment patterns, outcomes and healthcare resource utilization of obstructive hypertrophic cardiomyopathy in England.ESC Heart Fail2025https://conductscience.org/library/papers/39943699PubMed
39330348Advancements in the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Comprehensive Review.J Cardiovasc Dev Dis2024https://conductscience.org/library/papers/39330348PubMed
39175632Long-term follow-up study on obstructive hypertrophic cardiomyopathy patients treated with disopyramide: evidences of a notable trend in symptom control within a real-world clinical setting.Front Cardiovasc Med2024https://conductscience.org/library/papers/39175632PubMed
38269637A systematic review of present and future pharmaco-structural therapies for hypertrophic cardiomyopathy.Clin Cardiol2024https://conductscience.org/library/papers/38269637PubMed
37377648Clinical Trials in Hypertrophic Cardiomyopathy Therapy: A Comprehensive Analysis of Trials Registered in Global Clinical Databases.Drug Des Devel Ther2023https://conductscience.org/library/papers/37377648PubMed
36741099Mavacamten: A First-in-class Oral Modulator of Cardiac Myosin for the Treatment of Symptomatic Hypertrophic Obstructive Cardiomyopathy.Heart Int2022https://conductscience.org/library/papers/36741099PubMed
32185419[Hypertrophic cardiomyopathy].Herz2020https://conductscience.org/library/papers/32185419PubMed
25657602Hypertrophic cardiomyopathy: a review.Clin Med Insights Cardiol2014https://conductscience.org/library/papers/25657602PubMed
25634554Targets for therapy in sarcomeric cardiomyopathies.Cardiovasc Res2015https://conductscience.org/library/papers/25634554PubMed
25563291Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy.Curr Cardiol Rev2016https://conductscience.org/library/papers/25563291PubMed
22567198Hypertrophic Cardiomyopathy in a Young Adult with RV Aneurysm: Report of a Rare Finding and Review of the Literature.Heart Views2011https://conductscience.org/library/papers/22567198PubMed
18610277Treatment of hypertrophic obstructive cardiomyopathy with verapamil.Br Heart J1980https://conductscience.org/library/papers/18610277PubMed
15216199Calcium antagonists: A new class of therapeutic agents.Cardiovasc Dis1981https://conductscience.org/library/papers/15216199PubMed
11714423Medical therapy versus interventional therapy in hypertropic obstructive cardiomyopathy.Curr Control Trials Cardiovasc Med2000https://conductscience.org/library/papers/11714423PubMed
9594536[Clinical picture and therapy of hypertrophic cardiomyopathy].Med Klin (Munich)1998https://conductscience.org/library/papers/9594536PubMed
8924052Calcium channel antagonists in the modern era of coronary thrombolysis: benefit or detriment?Cardiovasc Drugs Ther1996https://conductscience.org/library/papers/8924052PubMed
7298378The role of calcium in the toxicity of the myocardium.Histochem J1981https://conductscience.org/library/papers/7298378PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/573129

GET https://conductscience.org/api/papers/v1/573129/cited_by?page=2